1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Hdm1002: new trials by email Literature Review of Hdm1002 trials Research Report on Hdm1002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults HDM1002 100 mg QD, HDM1002 200 mg QD 12weeks, HDM1002 400 mg QD 12weeks - Overweight and Obesity | Phase 2 | Unknown | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 180 | 2024-07-15 | 2024-07-15 |
Obesity (1) · Overweight (1)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (1)
Xiaoying Li (1)